Elon Musk's Neuralink receives FDA clearance

Elon Musk’s Neuralink brain chip company has received approval from US Food and Drug Administration (FDA) to conduct tests on humans.

The company plans to connect the human brain with computers to help them restore vision and mobility.

Musk said that the chips that his company developing hold the potential to address severe conditions like paralysis and blindness.

Elon Musk first talked about getting approval for human trials Neuralink’s brain implant back in 2019.

Neuralink is a neurotechnology company established in 2016, focused on developing implantable brain-machine interfaces (BMIs) that have the potential to connect human brains with computers. While the company has made significant advancements in the field of brain-machine interfaces, including the development of small and flexible electrode arrays, it wasn’t until early 2022 that it initiated the process for FDA approval.

Top image: Brain cells, Wikimedia